Three New Adjacent Bis-tetrahydrofuran Acetogenins with Four Hydroxyl Groups from Asimina triloba
- 1 January 1996
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 59 (11) , 1029-1034
- https://doi.org/10.1021/np9605145
Abstract
Three new adjacent bis-tetrahydrofuran ring Annonaceous acetogenins with four hydroxy groups, bullatetrocin (1), 10-hydroxyasimicin (2), and 10-hydroxytrilobacin (3), were isolated by activity-directed fractionation from the stem bark of Asimina triloba. Their structures were established on the basis of chemical and spectral evidence. The absolute stereochemistry at the C-10 hydroxy position was determined by converting 2 and 3 to their ketolactone isomers, 2,4-cis/trans 10-hydroxyasimicinones and 2,4-cis/trans 10-hydroxytrilobacinones, respectively. The bioactivities of the new compounds against brine shrimp larvae and six human solid-tumor cell lines are reported, and structure−activity relationships between trihydroxylated and tetrahydroxylated acetogenins are discussed. In addition to 1−3, gigantetrocin A, 2,4-cis/trans-gigantetrocin A-ones, annonacin, and annonacin A were also isolated for the first time from this species.Keywords
This publication has 6 references indexed in Scilit:
- Determination of absolute configuration of stereogenic carbinol centers in annonaceous acetogenins by proton and fluorine 19-NMR analysis of Mosher ester derivativesJournal of the American Chemical Society, 1992
- Brine Shrimp: A Convenient General Bioassay for Active Plant ConstituentsPlanta Medica, 1982
- Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginaseInternational Journal of Cancer, 1977
- New Human Tumor Cell LinesPublished by Springer Nature ,1975
- A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2JNCI Journal of the National Cancer Institute, 1973
- In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2JNCI Journal of the National Cancer Institute, 1973